Department of Pediatrics, University of Torino, Torino, Italy.
Am J Med Genet A. 2013 Oct;161A(10):2481-6. doi: 10.1002/ajmg.a.36080. Epub 2013 Aug 5.
Although Beckwith-Wiedemann syndrome (BWS, OMIM #130650) is the most common genetic overgrowth disorder, data on its epidemiology are scanty and the estimates of its occurrence show wide variability. The aim of this study is to assess its prevalence in Piedmont Region (Italy). We included in the study all patients diagnosed with BWS born in Piedmont from 1997 to 2009 through a search in the Italian Registry for Rare Diseases. This source was further validated with data from the network of Regional Clinical Genetics services and surveys in extra-regional Clinical Genetics centres, laboratories and the Italian BWS patients association. All cases were further ascertained through physical exam, medical history and specific molecular tests. The search identified 46 clear-cut cases of BWS born across the 13-year period, providing a prevalence of 1:10 340 live births (95% confidence interval 1:7,752-13,698 live births). Among the 41 patients who underwent molecular tests, 70.7% were positive, showing hypomethylation of the IC2 imprinting center (29.3%), paternal chromosome 11 uniparental disomy (pUPD11, 24.4%), IC1 hypermethylation (14.6%), CDKN1c mutation (2.4%), whereas 29.3% had negative molecular tests. The study provides an approximate BWS prevalence of 1:10,000 live birth, the highest reported to date.
尽管贝克威思-威德曼综合征(BWS,OMIM#130650)是最常见的遗传过度生长障碍,但关于其流行病学的数据很少,其发生率的估计差异很大。本研究旨在评估意大利皮埃蒙特地区(Piedmont Region)的患病率。我们通过在意大利罕见疾病登记处(Italian Registry for Rare Diseases)中搜索,纳入了 1997 年至 2009 年期间在皮埃蒙特出生的所有被诊断为 BWS 的患者。该来源还通过区域临床遗传学服务网络以及额外区域临床遗传学中心、实验室和意大利 BWS 患者协会的数据进行了验证。所有病例均通过体检、病史和特定的分子检测进一步确定。该搜索确定了 46 例在 13 年期间出生的明确 BWS 病例,患病率为每 10340 例活产 1 例(95%置信区间为每 7752-13698 例活产 1 例)。在接受分子检测的 41 例患者中,70.7%为阳性,显示印迹中心 IC2 的低甲基化(29.3%)、11 号染色体单亲二体性(pUPD11,24.4%)、IC1 高甲基化(14.6%)、CDKN1c 突变(2.4%),而 29.3%的患者分子检测为阴性。该研究提供了一个大约每 10000 例活产 1 例的 BWS 患病率,这是迄今为止报道的最高患病率。